z-logo
open-access-imgOpen Access
Use of Clinical Outcome Assessments in New Drug Approvals by the US Food and Drug Administration Divisions of Neurology I and II
Author(s) -
Yvette Schein,
Holly Fernandez Lynch
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.30530
Subject(s) - food and drug administration , drug , neurology , drug approval , medicine , administration (probate law) , drug administration , clinical pharmacology , new drug application , drug development , intensive care medicine , pharmacology , psychiatry , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom